ferric citrate has been researched along with losartan potassium in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Krehbiel, JD; Lund, JE; Weiss, DJ | 1 |
| Abe, M; Kitai, M; Maruyama, N; Maruyama, T; Nagura, C; Otsuki, T; Shibahara, N; Tomita, H; Yoshida, Y | 1 |
| Alikhani, L; Cogburn, K; Jing, W; Khazaeli, M; Lau, WL; Liu, H; Nunes, ACF; Said, H; Vaziri, ND; Zhao, Y | 1 |
1 trial(s) available for ferric citrate and losartan potassium
| Article | Year |
|---|---|
Ferric Citrate Decreases Fibroblast Growth Factor 23 and Improves Erythropoietin Responsiveness in Hemodialysis Patients.
Topics: Erythropoietin; Female; Ferric Compounds; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Lanthanum; Male; Middle Aged; Prospective Studies; Renal Dialysis; Treatment Outcome | 2018 |
2 other study(ies) available for ferric citrate and losartan potassium
| Article | Year |
|---|---|
Studies of the pathogenesis of anemia of inflammation: mechanism of impaired erythropoiesis.
Topics: Anemia; Animals; Cat Diseases; Cats; Cobalt; Erythrocyte Count; Erythropoiesis; Erythropoietin; Ferric Compounds; Hematocrit; Inflammation; Iron; Reticulocytes; Time Factors; Turpentine | 1983 |
Route of intestinal absorption and tissue distribution of iron contained in the novel phosphate binder ferric citrate.
Topics: Animals; Colon; Erythropoietin; Ferric Compounds; Hyperphosphatemia; Intestinal Absorption; Iron; Male; Phosphates; Rats; Rats, Sprague-Dawley; Renal Insufficiency, Chronic; Tissue Distribution | 2020 |